A woman in her 50s with a three-decade history of biopsy-proven focal segmental glomerulosclerosis and a family history of end-stage kidney disease presented with worsening proteinuria and declining ...

A contract buyout is when a team and a player mutually agree to terminate a contract prematurely, by having a player give up ...

The Herald was informed last week of a 15-year-old special-needs Chaparral High School student who is in need of a kidney ...

J.P. Morgan’s U.S. equity analysts picked their top stocks for 2025 in healthcare, selecting “the most compelling investment ...

Morgans healthcare and life sciences experts Iain Wilkie and Scott Power give Stockhead readers their top picks for 2025.

The acquisition combines the assets and capabilities of two companies founded by a leader in the GPR68 field, Professor Darren Kelly, consolidating a pipeline that now includes two Phase 2 and one ...

Fresolimumab is under clinical development by Sanofi and currently in Phase II for Non-Small Cell Lung Cancer.

最近报道了抗肾素抗体在移植后复发局灶节段性肾小球硬化（FSGS）中的可能作用。为了证实这些初步结果，该研究发现11例移植后复发性FSGS患者在移植前或复发时血浆抗肾素抗体较高。复发期间的移植物活检显示点状IgG沉积与nephrin共定位，随着neph ...

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA – Get Free Report) was the target of a large increase in short interest in November.

From AI to zygotes, the biotech sector this year delivered excitement, intrigue, occasional disappointment and downright ...